Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.59 USD | +1.41% | +0.28% | -16.90% |
Financials (USD)
Sales 2024 * | 104M | Sales 2025 * | 119M | Capitalization | 188M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 17M | EV / Sales 2024 * | 1.81 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.58 x |
P/E ratio 2024 * |
718
x | P/E ratio 2025 * |
11.6
x | Employees | 157 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.06% |
Latest transcript on Alimera Sciences, Inc.
1 day | +1.41% | ||
1 week | +0.28% | ||
Current month | -7.95% | ||
1 month | -9.80% | ||
3 months | -7.95% | ||
6 months | +15.43% | ||
Current year | -16.90% |
Managers | Title | Age | Since |
---|---|---|---|
David Holland
FOU | Founder | 60 | 03-06-03 |
Charles Myers
FOU | Founder | 70 | 03-06-03 |
Richard Eiswirth
CEO | Chief Executive Officer | 55 | 05-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Pizzo
BRD | Director/Board Member | 57 | 10-03-31 |
Richard Eiswirth
CEO | Chief Executive Officer | 55 | 05-09-30 |
Charles Myers
FOU | Founder | 70 | 03-06-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 3.59 | +1.41% | 16,176 |
24-04-22 | 3.54 | +5.99% | 25,959 |
24-04-19 | 3.34 | -2.91% | 48,043 |
24-04-18 | 3.44 | -3.10% | 56,785 |
24-04-17 | 3.55 | -0.84% | 4,391 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.90% | 188M | |
-2.86% | 87.37B | |
+4.08% | 41.01B | |
-25.35% | 28.08B | |
+53.74% | 24.72B | |
-4.52% | 17.47B | |
-42.09% | 11.69B | |
-17.77% | 11.6B | |
-12.10% | 11.56B | |
+0.75% | 8.44B |
- Stock Market
- Equities
- ALIM Stock